Treatment strategies for a rapidly evolving landscape in chronic lymphocytic leukemia management
TA Eyre, S Hori, T Munir - Hematological Oncology, 2022 - Wiley Online Library
With the advent of targeted therapies for chronic lymphocytic leukemia (CLL), treatment
choice has expanded and patients are living longer. Careful consideration is needed …
choice has expanded and patients are living longer. Careful consideration is needed …
Comparative Clinical Value of Pharmacologic Therapies for B-Cell Chronic Lymphocytic Leukemia: An Umbrella Analysis
M Marchetti, P Rivela, C Bertassello… - Journal of Clinical …, 2022 - mdpi.com
Several new drugs are progressively improving the life span of patients with B-cell chronic
lymphocytic leukemia (CLL). However, the rapidly evolving standard of care precludes …
lymphocytic leukemia (CLL). However, the rapidly evolving standard of care precludes …
Effect of Lenalidomide Maintenance in Chronic Lymphocytic Leukemia: A Meta-Analysis and Trial-Sequential Analysis
Chronic lymphocytic leukemia (CLL) is the most common lymphoproliferative disease in
adults. Despite durable responses and sustained remission rates to frontline therapy, CLL is …
adults. Despite durable responses and sustained remission rates to frontline therapy, CLL is …
Maintenance therapy for chronic lymphocytic leukaemia
Background Chronic lymphocytic leukaemia (CLL) is the most common lymphoproliferative
disease in adults and currently remains incurable. As the progression‐free period shortens …
disease in adults and currently remains incurable. As the progression‐free period shortens …
Terapija održavanja rituksimabom u kroničnoj limfocitnoj leukemiji
P Babić - 2022 - zir.nsk.hr
Sažetak UVOD: Kronična limfocitna leukemija (KLL) kronični je limfoproliferativni poremećaj
obilježen progresivnim nakupljanjem monoklonskih limfocita u krvi, koštanoj srži, limfnim …
obilježen progresivnim nakupljanjem monoklonskih limfocita u krvi, koštanoj srži, limfnim …
Frontline therapy CLL without 17p del/p53 aberrations: systematic review and Bayesian network meta-analysis
Background. Chronic Lymphocytic Leukemia (CLL) is the most common adult leukemia.
IgVh unmutated CLL without 17p del/p53 aberrations (UN-only CLL) still carry a poorer …
IgVh unmutated CLL without 17p del/p53 aberrations (UN-only CLL) still carry a poorer …
Real-world outcomes associated with chronic lymphocytic leukemia (CLL) therapies for patients treated in the United States Veterans Health Administration System
O Obodozie-Ofoegbu - 2021 - repositories.lib.utexas.edu
Chronic lymphocytic leukemia is the most predominant leukemia of all the hematologic
malignancies. It disproportionately afflicts older male Caucasians. It is classically considered …
malignancies. It disproportionately afflicts older male Caucasians. It is classically considered …
Fenntartó kezelési módok felnőttkori rosszindulatú hematológiai betegségekben
M Udvardy - Orvosi Hetilap, 2020 - akjournals.com
Absztrakt: A fenntartó kezelésmódok elsősorban a gyermekkori akut lymphoid
leukaemiában voltak általánosak, felnőttkorban ritkábbak. Fokozatosan alakultak ki fenntartó …
leukaemiában voltak általánosak, felnőttkorban ritkábbak. Fokozatosan alakultak ki fenntartó …